Cas 221297-53-6,3-[4-(methylsulfonyl)phenyl]-2-[4-(hydroxy)piperidin-1-yl]-5-trifluoromethyl-pyridine

221297-53-6

Post Buying Request

Basic information

Product Name: 3-[4-(methylsulfonyl)phenyl]-2-[4-(hydroxy)piperidin-1-yl]-5-trifluoromethyl-pyridine
Synonyms: 3-[4-(methylsulfonyl)phenyl]-2-[4-(hydroxy)piperidin-1-yl]-5-trifluoromethyl-pyridine
CAS NO:221297-53-6
Molecular Formula:
Molecular Weight: 400.422
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-[4-(methylsulfonyl)phenyl]-2-[4-(hydroxy)piperidin-1-yl]-5-trifluoromethyl-pyridine(CAS DataBase Reference)
NIST Chemistry Reference: 3-[4-(methylsulfonyl)phenyl]-2-[4-(hydroxy)piperidin-1-yl]-5-trifluoromethyl-pyridine(221297-53-6)
EPA Substance Registry System: 3-[4-(methylsulfonyl)phenyl]-2-[4-(hydroxy)piperidin-1-yl]-5-trifluoromethyl-pyridine(221297-53-6)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 221297-53-6(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

221297-53-6 Suppliers

Recommended suppliers

221297-53-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 221297-53-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,1,2,9 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 221297-53:
(8*2)+(7*2)+(6*1)+(5*2)+(4*9)+(3*7)+(2*5)+(1*3)=116
116 % 10 = 6
So 221297-53-6 is a valid CAS Registry Number.

221297-53-6Upstream product

221297-53-6Downstream Products

221297-53-6Relevant academic research and scientific papers

2-AMINOPYRIDINES AS INHIBITORS OF CYCLOOXYGENASE-2

-

Page/Page column 29, (2010/02/11)

The invention encompasses the novel compound of Formula (I) as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula (I).

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 221297-53-6